Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China

References

• Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371(9616):932–44. doi:10.1016/S0140-6736(08)60419-5.
   PubMed Web of Science ®Google Scholar
• Su SB, Chang HL, Chen AK. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health. 2020:17. doi:10.3390/ijerph17051686.
   PubMed Web of Science ®Google Scholar
• Lam E, Rosen JB, Zucker JR. Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity. Clin Microbiol Rev. 2020:33. doi:10.1128/CMR.00151-19.
   Web of Science ®Google Scholar
• McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1–34.
   PubMed Web of Science ®Google Scholar
• Beleni AI, Borgmann S. Mumps in the vaccination age: global epidemiology and the situation in Germany. Int J Environ Res Public Health. 2018:15. doi:10.3390/ijerph15081618.
   PubMed Web of Science ®Google Scholar
• Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT. Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report. Lancet Infect Dis. 2019;19(2):185–92. doi:10.1016/S1473-3099(18)30607-8.
   PubMed Web of Science ®Google Scholar
• Vygen S, Fischer A, Meurice L, Mounchetrou Njoya I, Gregoris M, Ndiaye B, Ghenassia A, Poujol I, Stahl JP, Antona D, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Euro Surveill. 2016;21(10):30156. doi:10.2807/1560-7917.ES.2016.21.10.30156.
   PubMedGoogle Scholar
• Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, et al. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. N Engl J Med. 2017;377(10):947–56. doi:10.1056/NEJMoa1703309.
   PubMed Web of Science ®Google Scholar
• Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, Dayan GH. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46(8):1172–80. doi:10.1086/529141.
   PubMed Web of Science ®Google Scholar
• Qin W, Wang Y, Yang T, Xu XK, Meng XM, Zhao CJ, Li SY, Xie SY, Li KC, Su H. Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination. Hum Vaccin Immunother. 2019;15(9):2106–11. doi:10.1080/21645515.2019.1581526.
   PubMed Web of Science ®Google Scholar
• Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, et al. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. BMJ. 2020;369:m1043. doi:10.1136/bmj.m1043.
   PubMed Web of Science ®Google Scholar
• Jiang RJ, Yin QZ, Xu MJ, Zhao ZM, Deng Y, Che YC. Epidemiological characteristics of mumps in mainland China from 2004 to 2018 and key population for prevention and control. Zhongguo Dang Dai Er Ke Za Zhi. 2019;21:441–44.
   PubMedGoogle Scholar
• Sun X, Tang F, Hu Y, Deng X, Wang Z, Zhou M, Liu Y. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China. Hum Vaccin Immunother. 2020;16(7):1738–42. doi:10.1080/21645515.2019.1708162.
   PubMed Web of Science ®Google Scholar
• Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L. Assessment of mumps-containing vaccine effectiveness during an outbreak: importance to introduce the 2-dose schedule for China. Hum Vaccin Immunother. 2018;14(6):1392–97. doi:10.1080/21645515.2018.1428508.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Z, Deng X, Hu Y, Wang Z, Lu P, Guo H, Sun X, Xu Y, Tang F, et al. Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study. Expert Rev Vaccines. 2018;17(5):445–52. doi:10.1080/14760584.2018.1445529.
   PubMed Web of Science ®Google Scholar
• WHO. Mumps virus vaccines. Wkly Epidemiol Rec. 2007; 82: 51–60.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases. 13thed; 2015. Chapter 15: Mumps. https://www.cdc.gov/vaccines/pubs/pinkbook/mumps.html
   Google Scholar
• Qin W, Xu XK, Wang Y, Meng XM, Yang CW, Xia F, Su H. Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks. Hum Vaccin Immunother. 2020:1–6. doi:10.1080/21645515.2019.1704574.
   PubMed Web of Science ®Google Scholar
• Plans-Rubió P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Hum Vaccin Immunother. 2012;8(2):184–88. doi:10.4161/hv.18444.
   PubMed Web of Science ®Google Scholar
• Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014–20. doi:10.1503/cmaj.101371.
   PubMed Web of Science ®Google Scholar
• Castilla J, García Cenoz M, Arriazu M, Fernández-Alonso M, Martínez-Artola V, Etxeberria J, Irisarri F, Barricarte A. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children. Vaccine. 2009;27(15):2089–93. doi:10.1016/j.vaccine.2009.02.001.
   PubMed Web of Science ®Google Scholar
• Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12–17. doi:10.3201/eid1301.060649.
   PubMed Web of Science ®Google Scholar
• Pang H, Zhou Y, Zhao W, Jiang Q. Seroprevalence and determinants associated with mumps antibodies after 20 years of MMR vaccination in urban area of Shanghai, China. Int J Environ Res Public Health. 2018:15. doi:10.3390/ijerph15102089.
   PubMed Web of Science ®Google Scholar
• Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, An der Heiden M, Andrews N, Pebody R, Aidyralieva C, Hahné S. Mumps outbreak in the Republic of Moldova, 2007-2008. Pediatr Infect Dis J. 2010;29(8):703–06. doi:10.1097/INF.0b013e3181d743df.
   PubMed Web of Science ®Google Scholar
• National Center for Immunization and Respiratory Diseases. General recommendations on immunization — recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1–64.
   PubMedGoogle Scholar
• Marin M, Marlow M, Moore KL, Patel M. Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morb Mortal Wkly Rep. 2018;67(1):33–38. doi:10.15585/mmwr.mm6701a7.
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Kanra G, Erdem G, Kanra B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Vaccine. 2001;19(31):4473–78. doi:10.1016/s0264-410x(01)00207-9.
   PubMed Web of Science ®Google Scholar